Regression of a Primary Pseudo-Tumoral Calcinosis Progressing During 16 Years under Combined Treatment with Acetazolamide and Aluminum Hydroxide: A Case Report
DOI:
https://doi.org/10.55677/IJCSMR/V3I4-02/2023Keywords:
Calcinosis, pseudo-tumoral, Acetazolamide, aluminum hydroxide, diet, evolution, FGF23.Abstract
Primary pseudo-tumoral calcinosis is a rare genetic disease due to a disorder of phosphorus metabolism characterized by the formation and deposition of calcium phosphate crystals in the peri-articular regions. The treatment is based on the reduction of hyperphosphatemia by hygienic and nutritional measures, hypophosphatemic drugs and surgery. We report the case of a 19-year-old patient followed since the age of 3 years for a primary pseudo-tumoral calcinosis that was resistant to surgery and that had well progressed with aluminum hydroxide and acetazolamide. Treatment combining aluminum hydroxide and acetazolamide with hygienic and nutritional measures seems to be an interesting therapeutic option for this pathology.
References
Chakhtoura M, Ramnitz M, Khoury N, Nemer G, Shabb N, Abchee A, et al. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature. Osteoporos Int. 2018 Sep;29(9):1987-2009.
Kışla Ekinci RM, Gürbüz F, Balcı S, Bişgin A, Taştan M, Yüksel B, et al. Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in GALNT3 Gene: Experience from Southern Turkey. Jcrpe. 2019 Mar 1;11(1):94-9
Ho BB, Bergwitz C. FGF23 signalling and physiology. Journal of Molecular Endocrinology. 2021 Feb;66(2):R23-R32.
Huang J, Cao LG, Zhang TR, Li SM, Meng QQ. Primary hyperphosphatemic tumoral calcinosis: a case report. Osteoporos Int. 2022 Jan;33(1):309-12.
Sandomenico F, Corvino A, Ronza FM, Catalano O, Fazioli F, De Chiara A, et al. Recurrence of tumoral calcinosis: a case report. Acta Biomed. 2019 12 23;90(4):587-94.
Fikri M, Allali N, Dafiri R. La calcinose tumorale a` propos de deux cas pédiatriques. J Radiol 2007;88:595–8.
Yamaguchi T, Sugimoto T, Imai Y, Fukase M, Fujita T, Chihara K. Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. Bone. 1995 Apr;16(4):S247-S250.
Finer G, Price HE, Shore RM, White KE, Langman CB. Hyperphosphatemic familial tumoral calcinosis: Response to acetazolamide and postulated mechanisms. Am J Med Genet. 2014 Jun;164(6):1545-9.
Fathi I. Review of tumoral calcinosis: A rare clinico-pathological entity. WJCC. 2014;2(9):409
Döneray H, Özden A, Gürbüz K. The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. Jcrpe. 2022 Jun 7;14(2):239-43.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 International Journal of Clinical Science and Medical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
